Literature DB >> 27431203

Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.

Justyna Mikuła-Pietrasik1, Paweł Uruski1, Sebastian Szubert2, Rafał Moszyński2, Dariusz Szpurek2, Stefan Sajdak2, Andrzej Tykarski1, Krzysztof Książek3.   

Abstract

Although undifferentiated tumors are the most lethal among all ovarian cancer histotypes, the exact reasons for this situation are unclear. This report was aimed at investigating whether the high aggressiveness of undifferentiated ovarian cancer may be associated with a biochemical composition of malignant ascites accumulating in the peritoneal cavity. We analyzed ascites from patients with undifferentiated, high-grade serous, endometrioid and clear-cell ovarian cancers, and from non-cancerous patients with respect to a group of soluble agents involved in cancer cell progression. Moreover, the effect of these fluids on proliferation and migration of ovarian cancer cells (A2780, OVCAR-3 and SKOV-3) was evaluated. The study showed that the level of all tested proteins in malignant ascites was higher than in the benign fluids. Concentration of 9/11 agents (CCL2, CXCL1, CXCL5, CXCL8, CXCL12, HGF, PAI-1, TGF-β1 and VEGF) was the greatest in the fluids from undifferentiated cancer, while the level of remaining 2 (IL-6 and uPA) was the highest in ascites from serous carcinoma. Proliferation of cancer cells was the most effective when they were subjected to ascites from patients with undifferentiated and serous cancer, whereas the migration was the highest in the case of undifferentiated tumors. Our findings indicate that the aggressiveness of undifferentiated ovarian tumors may be associated with the composition of malignant ascites, in particular the concentration of specific proinflammatory, cancer-promoting agents.

Entities:  

Keywords:  Cytokines; Malignant ascites; Ovarian cancer; Undifferentiated tumors

Mesh:

Year:  2016        PMID: 27431203     DOI: 10.1007/s12032-016-0810-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  15 in total

1.  Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells.

Authors:  Yue Wang; Jie Yang; Yan Gao; Yongrui Du; Leyuan Bao; Wenyan Niu; Zhi Yao
Journal:  Cell Mol Immunol       Date:  2005-10       Impact factor: 11.530

2.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

3.  Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.

Authors:  Isabelle Matte; Denis Lane; Claude Laplante; Perrine Garde-Granger; Claudine Rancourt; Alain Piché
Journal:  Int J Cancer       Date:  2014-12-18       Impact factor: 7.396

4.  Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.

Authors:  K Fischer; V Lutz; O Wilhelm; M Schmitt; H Graeff; P Heiss; T Nishiguchi; N Harbeck; H Kessler; T Luther; V Magdolen; U Reuning
Journal:  FEBS Lett       Date:  1998-10-30       Impact factor: 4.124

Review 5.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 6.  Early events in ovarian oncogenesis.

Authors:  Dusica Cvetkovic
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

7.  Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Authors:  Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Magdalena Zietarska; Véronique Ouellet; Patricia N Tonin; Mario Chevrette; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

Review 8.  Role of chemokines in tumor growth.

Authors:  Dayanidhi Raman; Paige J Baugher; Yee Mon Thu; Ann Richmond
Journal:  Cancer Lett       Date:  2007-07-12       Impact factor: 8.679

9.  MCP-1 promotes invasion and adhesion of human ovarian cancer cells.

Authors:  Shigenori Furukawa; Shu Soeda; Yuichiro Kiko; Osamu Suzuki; Yuko Hashimoto; Takafumi Watanabe; Hiroshi Nishiyama; Kazuhiro Tasaki; Hiroshi Hojo; Masafumi Abe; Keiya Fujimori
Journal:  Anticancer Res       Date:  2013-11       Impact factor: 2.480

10.  Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.

Authors:  Denis Lane; Isabelle Matte; Perrine Garde-Granger; Claude Laplante; Alex Carignan; Claudine Rancourt; Alain Piché
Journal:  BMC Cancer       Date:  2015-07-01       Impact factor: 4.430

View more
  12 in total

1.  Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.

Authors:  Kaitlin C Fogg; Carine M Renner; Hannah Christian; Alyssa Walker; Leilani Marty-Santos; Aisha Khan; Will R Olson; Carl Parent; Andrea O'Shea; Deneen M Wellik; Paul S Weisman; Pamela K Kreeger
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

Review 2.  The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer.

Authors:  Justyna Mikuła-Pietrasik; Szymon Rutecki; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.261

3.  Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells.

Authors:  Luai Al-Marzouki; Vivian S Stavrakos; Sanjima Pal; Betty Giannias; France Bourdeau; Roni Rayes; Nicholas Bertos; Sara Najmeh; Jonathan D Spicer; Jonathan Cools-Lartigue; Swneke D Bailey; Lorenzo Ferri; Veena Sangwan
Journal:  Gastric Cancer       Date:  2022-09-04       Impact factor: 7.701

4.  CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.

Authors:  Hiroaki Yasui; Hiroaki Kajiyama; Satoshi Tamauchi; Shiro Suzuki; Yang Peng; Nobuhisa Yoshikawa; Mai Sugiyama; Kae Nakamura; Fumitaka Kikkawa
Journal:  Clin Exp Metastasis       Date:  2019-09-21       Impact factor: 5.150

Review 5.  The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Andrzej Tykarski; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2017-09-27       Impact factor: 9.261

6.  The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Sebastian Szubert; Konstantin Maksin; Rafał Moszyński; Dariusz Szpurek; Aldona Woźniak; Stefan Sajdak; Andrzej Tykarski; Krzysztof Książek
Journal:  Biomed Res Int       Date:  2017-09-20       Impact factor: 3.411

7.  Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts.

Authors:  Paweł Uruski; Justyna Mikuła-Pietrasik; Martyna Pakuła; Sylwia Budkiewicz; Marcin Drzewiecki; Andrey N Gaiday; Małgorzata Wierzowiecka; Eryk Naumowicz; Rafał Moszyński; Andrzej Tykarski; Krzysztof Książek
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

8.  Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice.

Authors:  Ulises Urzua; Carlos Chacon; Luis Lizama; Sebastián Sarmiento; Pía Villalobos; Belén Kroxato; Katherine Marcelain; María-Julieta Gonzalez
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

9.  Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites.

Authors:  Jie Jiao; Chengzhen Li; Guanying Yu; Lei Zhang; Xiaoyan Shi; Jingdu Yan; Houjun Zhang; Peiming Guo
Journal:  World J Surg Oncol       Date:  2020-07-22       Impact factor: 2.754

10.  Patient-Specific Variables Determine the Extent of Cellular Senescence Biomarkers in Ovarian Tumors In Vivo.

Authors:  Paweł Uruski; Justyna Mikuła-Pietrasik; Eryk Naumowicz; Kamila Kaźmierczak; Andrey N Gaiday; Jan Królak; Błażej Nowakowski; Rafał Moszyński; Andrzej Tykarski; Krzysztof Książek
Journal:  Biomedicines       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.